1. Mendelian
  2. Rare Diseases
  3. THYROID CANCER, NONMEDULLARY, 1; NMTC1

Thyroid Cancer, Nonmedullary, 3; Nmtc3

Table of contents:

Description

Nonmedullary thyroid cancer (NMTC) comprises thyroid cancers of follicular cell origin and accounts for more than 95% of all thyroid cancer cases. The remaining cancers originate from parafollicular cells (medullary thyroid cancer, MTC; {155240}). NMTC is classified into 4 groups: papillary, follicular, Hurthle cell (OMIM ), and anaplastic. Approximately 5% of NMTC is hereditary, occurring as a minor component of a familial cancer syndrome (e.g., familial adenomatous polyposis {175100}, Carney complex {160980}) or as a primary feature (familial NMTC or FNMTC). Papillary thyroid cancer (PTC) is the most common histologic subtype of FNMTC, accounting for approximately 85% of cases (summary by Vriens et al., 2009).For a general phenotypic description and a discussion of genetic heterogeneity of NMTC, see NMTC1 (OMIM ).

Clinical Features

Phenotypes and symptoms related to Thyroid Cancer, Nonmedullary, 3; Nmtc3

  • Neoplasm
  • Medullary thyroid carcinoma
  • Non-medullary thyroid carcinoma

Incidence and onset information

— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
— No data available about the known clinical features onset.

Alternative names

Thyroid Cancer, Nonmedullary, 3; Nmtc3 Is also known as thyroid cancer, nonmedullary, 1, formerly, nmtc1, formerly.

Researches and researchers

Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.

Sources and references

You can check the following sources for additional information.

OMIM Rare Disease Symptoms Checker

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET; NADGP 3MC SYNDROME 3; 3MC3 SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS 2Q24 MICRODELETION SYNDROME PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY; PNPOD HOLOPROSENCEPHALY 2; HPE2